drugset / Trial / NCT00742573
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
Phase 2
Completed
170 enrolled
New York State Psychiatric Institute
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.
Timeline
- Start
- 2008-08
- Primary completion
- 2014-01-10
- Completion
- 2014-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupropion | Small molecule | — | — |
| Subject | Citalopram | Small molecule | — | — |
| Subject | Duloxetine | Small molecule | — | — |
| Subject | Escitalopram | Small molecule | — | — |
| Subject | Mirtazapine | Other / unclassified | — | — |
| Subject | Nortriptyline | Small molecule | — | — |
| Subject | Paroxetine | Small molecule | — | — |
| Subject | Sertraline | Small molecule | — | — |
| Subject | Venlafaxine | Small molecule | — | — |